Delivery Order SPE2DB24D1205-SPE2DB24FCTPP
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the delivery of 4,568,434,774 units of Vyvanse 40 mg capsules. The contract has a firm fixed price of $2,350.74 and a completion date of June 4, 2025. This is a non-set-aside delivery order contract, indicating open competition. Amerisourcebergen Drug Corp is a key supplier of pharmaceutical products and medical supplies to various...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,110,605 units of the pharmaceutical drug Vyvanse 40 mg capsule. The contract has a total ceiling value of $4,796.63 and a completion date of October 16, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWEW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,058,212 units of Vyvanse 40 mg capsules, with a ceiling value of $2,290.97. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp,...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,761.14 firm fixed-price delivery order is for the supply of 100 units of Vyvanse 40 mg capsules. The contract has a completion date of September 6, 2024, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,232.12 firm-fixed-price delivery order is for the supply of 4,565,618,784 units of Vyvanse 40mg capsules. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $15,115.44 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,699,665 units of Vyvanse 50 mg capsules. This contract has a completion date of September 6, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,728,779 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $2,675.40 and a period of performance through December 17, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,552,572,418 units of Vyvanse 40 mg capsules. The contract has a ceiling value of $4,034.48 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 through November 2026. This IDC serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,849.36 firm-fixed-price delivery order is for the provision of 4,563,139,143 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen is the prime contractor, with no mentioned subcontractors. This award is part of a larger $999,999,999 Indefinite...